An open label, parallel,randomised study of denosumab versus Zoledronic acid in post menopausal women treated with Zoledronic acid

Trial Profile

An open label, parallel,randomised study of denosumab versus Zoledronic acid in post menopausal women treated with Zoledronic acid

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2016

At a glance

  • Drugs Denosumab (Primary) ; Zoledronic acid
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top